Central finding #
Paper (Results): “…one child was hospitalized for pneumonia… Parents of 30 children indicated that medical care was unrelated to vaccination, 11 parents completed a VAERS report, and two parents indicated that the report was made in error.”
Paper (Abstract / VAERS): “…serious adverse events are rare.” Eight VAERS serious reports; “no evidence suggested that these reported events were related to vaccination.”
The MMWR’s pitch is mild reactogenicity, ~3% medical care mostly waved off as unrelated or infection, one pneumonia hospitalization, VAERS serious events reviewed and ruled unrelated, and counseling that serious adverse events are rare.
Compared to the v-safe dataset (~1,490 reconstructed; paper 2,969): the week-1 pneumonia hospital case
is present and coded Hospitalisation; Pneumonia—but GDIT Unsuccessful.
Post-dose Dyspnoea 5, Chest pain 2, Seizure 1 are unpublished.
Later Hospitalization checkboxes include Epilepsy/Seizure and Type 1 diabetes—themes
already named then dismissed in the VAERS serious list.
Full write-up: vsafe-analysis/mmwr/mm7223a2/anomalies_report.md.
A. The one week-1 hospitalization — coded, but follow-up failed #
Paper (Results / Table 1): Hospitalization = 1 (0.03%); “one child was hospitalized for pneumonia.”
Registrant TCZ-31016-55374 (Pfizer dose 3, 14 Sep 2022): day 6 Clinic + ER + Hospitalization;
MedDRA Hospitalisation; Pneumonia; GDIT Unsuccessful.
Why this matters: Readers remember “one pneumonia hospitalization” inside a paragraph dominated by “unrelated to vaccination.” They do not see that the hospital case’s call-center outcome can be a failed closeout.
B. Medical care waved off as “unrelated” #
Paper (Results): Of those with call-center information, 30 said medical care was unrelated, 11 completed VAERS, 2 said the report was in error.
Among week-1 medical-care reporters with a GDIT outcome: about Successful 23 / Unsuccessful 20. Nearly half never closed successfully. Week-1 ER: 7 response rows (including the hospital case).
C. Chest pain, dyspnea, seizure — unpublished next to “SAEs rare” #
Paper: “…serious adverse events are rare.” VAERS: eight serious reports (incl. afebrile seizure ×2, Kawasaki, pneumonia, DKA)—ruled unrelated after review.
Post-dose MedDRA: Dyspnoea 5, Chest pain 2, Seizure 1, Hospitalisation 2, Unevaluable event 13. Free text includes multiple pneumonia narratives, RSV requiring breathing treatments / hospital stay, and croup with trouble breathing.
Why this matters: VAERS gets a serious-event table emptied by “not related after review.” Leaving parallel v-safe dyspnea / chest-pain / seizure coding off the Results page understates active surveillance beside “SAEs rare.”
Post-dose chest / dyspnea / seizure / Hospitalisation MedDRA.
Serious free-text narratives.
D. Later hospitalization checkboxes #
After day 7: hemolytic anemia free text, RSV hospital stay, Epilepsy; Seizure,
Type 1 diabetes mellitus (two registrants)—mostly hosp_pt_present = N.
These themes parallel VAERS serious impressions the paper declares unrelated after review.
E. Deaths / myocarditis — none under post-dose coding #
No post-third-dose MedDRA Death, Myocarditis, or Pericarditis through mid-June 2023. The gaps are soft medical-care framing, unpublished dyspnea/chest-pain/seizure coding, and later hospital checkboxes.
Summary #
- Follow-up gap: week-1 pneumonia hospitalization coded correctly but GDIT Unsuccessful
- Soft framing: “30 unrelated” story beside ~20/43 Unsuccessful GDIT among care seekers
- Reporting gap: Dyspnoea 5 / Chest pain 2 / Seizure 1 unpublished next to “SAEs rare”
- Later care: Hospitalization checkboxes with seizure and type 1 diabetes themes; mostly no Hospitalisation PT
Bottom line: Compared to the v-safe dataset, this brief gets everyday reactogenicity and the single week-1 pneumonia hospitalization roughly right—but wraps care-seeking in “unrelated” language while follow-ups often fail, leaves dyspnea / chest-pain / seizure coding off the v-safe Results page beside “serious adverse events are rare,” and never surfaces later hospital checkboxes that carry seizure and type 1 diabetes themes already named then dismissed in the VAERS serious list.